To Study the Effects of Baby Drink on Vision Care
1 other identifier
interventional
60
1 country
1
Brief Summary
Baby Drink is a formula based on lutein, mixed with blueberry fermented liquid, vitamins and minerals. Lutein is an effective antioxidant to prevent retinal damage caused by blue light, but it cannot be produced in the human body and depends on dietary intake. Blueberry fermented liquid is rich in polyphenolic compounds with excellent antioxidant capacity and the potential to reduce oxidative damage to eye cells caused by ultraviolet rays. With the prevalence of 3C products, myopia patients are increasing year by year in various regions, and suffer from eye diseases or vision loss with different degrees of complications. In this study, the subjects were provided with Baby Drink and tracked the degree of visual fatigue by regular questionnaires, and measured for visual acuity, axial length and diopter. The aim of this study is to investigate the protection of Baby Drink on visual acuity and visual fatigue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Mar 2023
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2023
CompletedStudy Start
First participant enrolled
March 8, 2023
CompletedFirst Posted
Study publicly available on registry
March 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedMarch 21, 2023
March 1, 2023
9 months
March 8, 2023
March 19, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Eye fatigue questionnaire
1. Eye fatigue were evaluated according to The Ocular Surface Disease Index (OSDI) introduced in 1997 by the Outcomes Research Group (Allergan Inc., Irvine, CA). 2. Content including: (1) Eye swelling, (2) Eye soreness, (3) Photophobia, (4) Blurred vision, (5) Dry eye, (6) Foreign body sensation, (7) Tearing, (8) General discomfort related to eye fatigue. 3. Scores are expressed on a scale of 0-3. 0 = No symptoms , 1 = Occasionally (≤1 time/day), 2 = Sometimes (1-3 times/day), 3 = Frequently (\>3 times/day), a low score means less visual fatigue and better eye quality.
1 month
Best vision test
1. Visual acuity was tested with the Snellen Eye Test Chart and recorded with the score proposed by Snellen. 2. Subjects were asked to stand 20 feet away to observe the snellen E-chart and record the smallest visual mark. 3. Recording method: 20/20 (1.0) is defined as normal vision, lower than this score indicates that the subject has ametropia, and higher than this indicates that the subject's vision is higher than the general standard
1 month
Study Arms (1)
Baby Drink group
EXPERIMENTAL1 package/ day for 1 month
Interventions
Eligibility Criteria
You may qualify if:
- Adults aged 20 or over
- Willing to participate in this study and sign the subject's consent form
- Myopia less than 700 degrees
You may not qualify if:
- Have consumed related eye care products in past 3 months
- Those who have eye infection in the past 3 months
- People who have been diagnosed with any eye diseases in past 3 months
- Those who are allergic to cicadae
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asia university
Taichung, 413, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Wen Lin, ph.D
Asia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
March 8, 2023
First Posted
March 21, 2023
Study Start
March 8, 2023
Primary Completion
December 15, 2023
Study Completion
December 15, 2023
Last Updated
March 21, 2023
Record last verified: 2023-03